Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Drug Delivery

News in brief

Biocon introduces insulin pen to Indian market


Biocon has begun selling a reusable insulin pen, based on Haselmeier technology, to patients in India.

INSUPen is being used to deliver two Biocon insulin products: Basalog, a long-lasting formulation; and Insugen, a recombinant human form. By delivering the products using the i-pen technology from Haselmeier Biocon hopes to ensure reliable and accurate dosing while increasing convenience.


Rakesh Bamzai, president, marketing at Biocon, said: “I am confident that INSUPen will be a delight for patients and a value enhancer for all stakeholders.” The i-pen includes dose correction to avoid errors and other features designed to ease self-administration by patients.

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE

Key Industry Events


Access all events listing

Our events, Events from partners...